{"organizations": [], "uuid": "aa639016f2ac5c12a438749d9e291ca218a9e4cf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180510.html", "section_title": "Archive News &amp; Video for Thursday, 10 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-charles-river-laboratories-announc/brief-charles-river-laboratories-announces-first-quarter-2018-results-from-continuing-operations-idUSL8N1SH473", "country": "US", "domain_rank": 408, "title": "BRIEF-Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-05-10T19:34:00.000+03:00", "replies_count": 0, "uuid": "aa639016f2ac5c12a438749d9e291ca218a9e4cf"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-charles-river-laboratories-announc/brief-charles-river-laboratories-announces-first-quarter-2018-results-from-continuing-operations-idUSL8N1SH473", "ord_in_thread": 0, "title": "BRIEF-Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "charles river laboratories international inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 10 (Reuters) - Charles River Laboratories International Inc:\n* CHARLES RIVER LABORATORIES ANNOUNCES FIRST-QUARTER 2018 RESULTS FROM CONTINUING OPERATIONS\n* Q1 NON-GAAP EARNINGS PER SHARE $1.38\n* Q1 GAAP EARNINGS PER SHARE $1.08 * Q1 REVENUE $494 MILLION VERSUS I/B/E/S VIEW $480.3 MILLION\n* Q1 EARNINGS PER SHARE VIEW $1.26 — THOMSON REUTERS I/B/E/S\n* UPDATES 2018 GUIDANCE * REAFFIRMING ITS ORGANIC REVENUE GROWTH GUIDANCE FOR 2018.\n* IS INCREASING 2018 GUIDANCE FOR REPORTED REVENUE GROWTH * IS INCREASING ITS NON-GAAP EARNINGS PER SHARE GUIDANCE FOR 2018\n* SEES 2018 NON-GAAP EPS $5.77 - $5.92\n* SEES 2018 REVENUE GROWTH, REPORTED 18% - 20%\n* SEES 2018 GAAP EPS $4.22-$4.37\n* CHARLES RIVER LABORATORIES INTERNATIONAL - 2018 EARNINGS PER SHARE GUIDANCE OF $4.22 TO $4.37 INCLUDES MPI RESEARCH DEAL\n* FY2018 EARNINGS PER SHARE VIEW $5.76, REVENUE VIEW $2.18 BILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-10T19:34:00.000+03:00", "crawled": "2018-05-11T12:36:50.005+03:00", "highlightTitle": ""}